Core Viewpoint - The company, Zhongji Health Industry Co., Ltd., has disclosed its third-quarter report for 2025, ensuring the accuracy and completeness of the information provided [10][14]. Financial Data - The third-quarter report has not been audited [9][10]. - There are no adjustments or restatements required for previous accounting data [4]. - The company does not have any non-recurring gains or losses to report [4]. Shareholder Information - The company has received a pre-restructuring notice from the court regarding its subsidiary, Xinjiang Zhongji Red Tomato Industry Co., Ltd., indicating the initiation of a restructuring process [6]. - The restructuring will involve the recruitment of investors, with a primary investor identified as Xinjiang Xinye State-owned Assets Management Group Co., Ltd. [6]. Board and Supervisory Meetings - The board of directors and the supervisory board have both approved the third-quarter report during their respective meetings held on October 27, 2025 [10][14]. - All members of the board and supervisory board confirmed the accuracy and completeness of the announcements made [10][14].

Core Viewpoint - *ST Zhongji reported a significant decline in net profit for the first three quarters of 2025, despite an increase in revenue, indicating potential financial distress and operational challenges [1][2]. Financial Performance - The company's revenue for the first three quarters of 2025 was 354 million yuan, representing an 18.92% year-on-year increase [1]. - The net profit attributable to shareholders was -144 million yuan, a decrease of 230.90% year-on-year [1]. - The non-recurring net profit attributable to shareholders was -207 million yuan, down 348.55% year-on-year [1]. - Basic earnings per share were -0.19 yuan [2]. Profitability Metrics - The gross margin for the first three quarters of 2025 was -6.93%, a decline of 20.90 percentage points year-on-year [2]. - The net margin was -42.63%, down 28.22 percentage points compared to the same period last year [2]. - In Q3 2025, the gross margin was -14.06%, a year-on-year decrease of 12.48 percentage points [2]. - The net margin for Q3 2025 was -67.59%, which increased by 37.24 percentage points year-on-year [2]. Expense Analysis - Total operating expenses for the period were 104 million yuan, an increase of 51.08 million yuan year-on-year [2]. - The expense ratio was 29.41%, up 11.59 percentage points from the previous year [2]. - Sales expenses decreased by 39.26%, while management expenses surged by 190.14% [2]. - R&D expenses fell by 55.18%, and financial expenses rose by 60.30% [2]. Shareholder Information - As of the end of Q3 2025, the total number of shareholders was 25,500, an increase of 233 from the end of the previous half [2]. - The average market value of shares held per shareholder rose from 108,500 yuan to 109,600 yuan, reflecting a 1.04% increase [2]. Company Overview - Zhongji Health Industry Co., Ltd. is located in Wujiaqu City, Xinjiang, and was established on June 30, 1994, with its stock listed on September 26, 2000 [3]. - The company's main business involves the production and deep processing of tomato products, with the primary revenue sources being bulk raw sauce (88.37%), lycopene (5.77%), and other products [3]. - The company is classified under the agricultural and forestry industry, specifically in the processing of fruits and vegetables [3].

中基健康产业股份有限公司（以下简称"公司"）第十届监事会第十次临时会议于 2025 年 10 月 27 日（星期一）以传真通讯方式召开，本次会议于 2025 年 10 月 22 日以电子邮件方式 发出会议通知。在确保公司全体监事充分了解会议内容的基础上，公司 3 名监事在规定的时间 内参加了表决。会议的召开符合《公司法》和《公司章程》的有关规定。会议审议并通过了如 下决议： 一、审议通过《2025 年第三季度报告》。 证券代码：000972 证券简称：*ST中基 公告编号：2025-093号 中基健康产业股份有限公司 第十届监事会第十次临时会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 表决结果：同意 3 票；反对 0 票；弃权 0 票。 详见公司于同日披露的《2025 年第三季度报告》。 特此公告。 中基健康产业股份有限公司监事会 2025 年 10 月 27 日 ...

证券代码：000972 证券简称：*ST 中基 公告编号：2025-092 号 中基健康产业股份有限公司 第十届董事会第十七次临时会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 中基健康产业股份有限公司（以下简称"公司"）第十届董事会第十七次临时会议于 2025 年 10 月 27 日（星期一）以传真通讯方式召开，本次会议于 2025 年 10 月 22 日以电子邮件方 式发出会议通知。在确保公司全体董事充分了解会议内容的基础上，公司 9 名董事在规定的时 间内参加了表决。会议的召开符合《公司法》和《公司章程》的有关规定。会议审议并一致通 过了如下决议： 一、审议通过《2025 年第三季度报告》。 表决结果：同意 9 票；反对 0 票；弃权 0 票。 详见公司于同日披露的《2025 年第三季度报告》。 特此公告。 中基健康产业股份有限公司董事会 2025 年 10 月 27 日 ...

Financial Performance - The company's operating revenue for the current period is ¥109,239,299.24, representing a year-on-year increase of 107.32%[5] - The net profit attributable to shareholders of the listed company is -¥68,229,862.97, with a year-to-date net profit of -¥144,087,480.95[5] - Total operating revenue for the current period reached CNY 354,172,619.51, an increase of 19% compared to CNY 297,820,015.92 in the previous period[20] - Net loss for the current period was CNY -150,986,842.99, compared to a net loss of CNY -42,913,551.68 in the previous period, reflecting a significant decline in profitability[21] - The company reported a basic and diluted earnings per share of CNY -0.1868, compared to CNY -0.0565 in the previous period[21] Assets and Liabilities - The total assets at the end of the reporting period amount to ¥1,248,281,653.41, a decrease of 28.24% compared to the end of the previous year[5] - The company's total assets decreased to CNY 1,248,281,653.41 from CNY 1,739,625,960.93 in the previous period, reflecting a significant contraction in asset base[18] - Total liabilities amounted to CNY 1,415,955,682.45, down from CNY 1,756,688,135.47 in the previous period, indicating a reduction in overall debt[18] - The company's equity attributable to shareholders was reported at CNY -171,455,526.61, a decline from CNY -27,368,045.66 in the previous period[19] Cash Flow - The cash flow from operating activities for the year-to-date is -¥37,369,039.83[5] - Cash flow from operating activities decreased to CNY 262,907,647.90, down from CNY 380,194,887.13 in the previous period, indicating a decline in cash generation[22] - Net cash flow from operating activities was -$37.37 million, compared to -$12.08 million in the previous period, indicating a decline in operational cash generation[23] - Total cash inflow from financing activities was $219.08 million, down from $501.93 million in the previous period, reflecting a significant decrease in financing[23] Inventory and Expenses - The company’s inventory decreased by 44.48% to ¥546,062,861.72, primarily due to increased sales of large barrel sauce[8] - Total operating costs increased to CNY 484,958,167.04, up 55.5% from CNY 311,484,738.21 in the previous period[20] - The company’s financial expenses increased by 60.30% to ¥32,815,847.47, mainly due to higher interest expenses on bank loans[9] Strategic Changes - The company has initiated a pre-restructuring process with the Xinjiang Production and Construction Corps Sixth Division Intermediate People's Court, indicating potential strategic changes ahead[13] - A restructuring investment agreement was signed with multiple financial investors, which may influence future capital structure and operational strategies[14] - The company is actively seeking restructuring investors to enhance its financial stability and operational efficiency[13] - The company’s total liabilities and equity structure will be reassessed as part of the restructuring process, which may lead to significant changes in financial strategy[14]

证券代码：000972 证券简称：*ST 中基 公告编号：2025-090 号 中基健康产业股份有限公司 关于收到《租赁资产转让通知书》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大 遗漏。 一、基本情况 中基健康产业股份有限公司（以下简称"公司"）于近日收到了邦银金融租赁股份有限公 司（以下简称"邦银金融租赁"）与新疆新动能融资租赁有限公司（以下简称"新动能融资租 赁"）共同出具的《租赁资产转让通知书》，邦银金融租赁已将其对公司全资子公司新疆中基 红色番茄产业有限公司（以下简称"红色番茄"）及其下属控股公司五家渠中基天兴番茄制品 有限责任公司（以下简称"中基天兴"）在租赁合同项下全部应收租金、违约金、风险抵押金、 保险金、损失赔偿金、补偿金、约定损失赔偿金及其他应付款项所享有的全部债权及相关权益 以及担保权益转让给新动能融资租赁。租赁合同项下租赁物所有权由邦银金融租赁转移至新动 能融资租赁；新动能融资租赁作为债权人有权要求领受红色番茄及中基天兴根据租赁合同原应 向邦银金融租赁清偿和履行的一切债务和义务；同时，根据相关法律规定，邦银金融租赁作为 担保权人在《保 ...

Core Viewpoint - The company has received a notice regarding the transfer of leasing assets, indicating a change in the creditor and lessor for its subsidiaries without significant adverse effects on its operations [1] Group 1: Asset Transfer Details - The company announced that Bangyin Financial Leasing has transferred all its claims and related rights under the leasing contract for its subsidiaries, Hongse Fanqie and Zhongji Tianxing, to New Momentum Financial Leasing [1] - The ownership of the leased assets has also been transferred to New Momentum Financial Leasing [1] Group 2: Impact on Operations - The transfer results in a change of lessor and creditor under the guarantee contract, but it does not have a significant negative impact on the company's production and operations [1]

Core Insights - The agricultural processing sector experienced a decline of 0.49% on October 20, with Baolingbao leading the drop [1] - The Shanghai Composite Index closed at 3863.89, up 0.63%, while the Shenzhen Component Index closed at 12813.21, up 0.98% [1] Sector Performance - The following companies in the agricultural processing sector showed notable performance: - *ST Jiawo (300268): Closed at 10.47, up 3.97% with a trading volume of 16,000 shares and a turnover of 16.58 million yuan [1] - ST Langyuan (300175): Closed at 6.15, up 3.71% with a trading volume of 77,000 shares and a turnover of 47.05 million yuan [1] - Guotou Zhonglu (600962): Closed at 20.73, up 1.67% with a trading volume of 27,100 shares and a turnover of 56.22 million yuan [1] - *ST Zhongxi (000972): Closed at 3.84, up 1.32% with a trading volume of 110,400 shares and a turnover of 41.99 million yuan [1] - Tianye Co., Ltd. (920023): Closed at 4.27, up 1.18% with a trading volume of 43,300 shares and a turnover of 18.48 million yuan [1] Capital Flow - The agricultural processing sector saw a net outflow of 233 million yuan from main funds, while retail investors contributed a net inflow of 166.7 million yuan [3] - Speculative funds recorded a net inflow of 66.6 million yuan into the sector [3]

New Stock Issuance - New stock issuance includes 泰凯英 (code: 920020) at an issuance price of 7.50 and 超颖电子 (code: 732175) at 17.08[1] Equity Market Alerts - 上纬新材 (code: 688585) is undergoing a tender offer from September 29, 2025, to October 28, 2025[1] - 科思科技 (code: 688788) and 博瑞医药 (code: 688166) have recent announcements dated September 26, 2025, and October 10, 2025, respectively[1] - 南新制药 (code: 688189) reported severe abnormal fluctuations on October 10, 2025[1] Trading Alerts - A total of 50 stocks have trading alerts with the latest announcements on October 15, 2025, including 国光连锁 (code: 605188) and 中持股份 (code: 603903)[1] - The lowest trading alert price recorded is 1,116 for 赛恩斯 (code: 688480)[1]

Core Insights - The agricultural processing sector saw a 0.8% increase on October 15, with Zunming Co. leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] Agricultural Processing Sector Performance - Zunming Co. (003030) closed at 19.54, up 5.51% with a trading volume of 38,800 lots and a transaction value of 74.5 million yuan [1] - Guangnong Sugar Industry (000911) closed at 7.68, up 4.77% with a trading volume of 236,200 lots and a transaction value of 183 million yuan [1] - Yongshuntai (001338) closed at 11.98, up 4.63% with a trading volume of 269,200 lots and a transaction value of 324 million yuan [1] - Other notable performers include Guotou Zhonglu (600962) at 21.99 (+3.82%), Baolingbao (002286) at 9.97 (+3.10%), and Suobao Protein (603231) at 19.05 (+1.65%) [1] Capital Flow Analysis - The agricultural processing sector experienced a net inflow of 23.09 million yuan from main funds, while retail funds saw a net outflow of 23.04 million yuan [2] - Main funds showed significant inflows in Yongshuntai (6.01 million yuan) and Guangnong Sugar Industry (2.88 million yuan) [3] - Retail investors had notable outflows in Yongshuntai (-40.62 million yuan) and Guangnong Sugar Industry (-24.46 million yuan) [3]